Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634062 · ClinicalTrials.gov registry record · Phase 4
Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder
A Phase 4 study, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00634062 is a Phase 4 study that has completed, run by Mclean Hospital. The registered enrollment target is 28 participants.
The verdict
NCT00634062, a Phase 4 study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study investigates the hypothesis that instability in mood in patients with borderline personality disorder will respond the mood stabilizing medication lamotrigine.
Interventions
- DRUG Placebo
- DRUG Lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634062
The ClinicalTrials.gov registry entry for NCT00634062 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00634062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00634062 about?
NCT00634062 is a clinical study titled "Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder". This study investigates the hypothesis that instability in mood in patients with borderline personality disorder will respond the mood stabilizing medication lamotrigine.
What is the current status of trial NCT00634062?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2004-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00634062?
The interventions under investigation include: Placebo (DRUG), Lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00634062?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.